My break-even exit is 10.5c, so in the event of rejection by the FDA I would expect to be able to exit pretty much on the day.FDA was our aim in 2017 but the trial results were not fit for purpose so we didn't proceed. Saying it's not a failure because we decided not to proceed is a matter of semantics. The reality is in the share price action at the time.
2020 The Year Of RAP, page-484
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #